HDAC6 thus plays a central role in AD pathophysiology and is considered a suitable pharmacological target, though its exact role—whether in amyloid deposition, neuroinflammation, or other neuropathological changes—remains to be clarified [65]. This evidence concerns the gene HDAC6 and Alzheimer disease.